Heart Disease – Discover Pharma

Welcome to Discover Pharma! Today is : October 17, 2026

Heart Disease

Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Researchers develop human iPS cell model of heart failure
Researchers have developed a human iPS-cell-derived heart tissue model of [...]

September 16, 2026
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Isomab data support safety of angiogenic approaches in coronary artery disease
A systematic review of more than two decades of clinical [...]

September 4, 2026
Digital & Data
Qureight expands London operations to develop AI chest imaging model
Qureight has opened a second UK site in London as [...]

August 19, 2026
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development
Qureight raises $20 million to expand AI imaging platform into new lung and heart diseases
Qureight has raised $20 million in a Series B financing [...]

July 30, 2026
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development
Qureight raises $20 million to expand AI imaging platform for clinical trials
Qureight has raised $20 million in a Series B financing [...]

July 29, 2026
Clinical & Regulatory
Eli Lilly’s Lepodisiran cuts heart disease risk factor by 94% in Phase 2 trial
May 5, 2026

main menu

recent posts

get connected

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK